Sign in or register to see full information and data.

Studies / CAVD 504

Overview

Study information

Network:CAVD
Grant Affiliation:Haynes: B cell Lineage Envelope Design from RV144 Antibodies
Strategy:Combo: Protein & vector vaccines
Study Type:Antibody Screening
Species:Human
Stage:Assays Completed
Study Start Date:2015-08-28
Study Made Public:2016-07-20

Title

CM244 neutralization activity of memory B cell culture supernatants and recombinant mAbs from an RV305 patient

Description

CAVD 504 is an immunogenicity study to evaluate the neutralization activity of supernatants from memory B cell culture plates from a subject in RV305, the boost study to RV144.

Products

ALVAC (vCP1521) AIDSVAX B/E Saline (non-specific) Placebo ALVAC Placebo AIDSVAX B/E

Integrated data

No integrated data is available for this study.

Non-integrated data

No non-integrated data is available for this study.